- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
A Climate of Compliance
In the interests of helping drug makers prepare for the new legislative climate, database and software provider Cegedim recently organized a seminar.
In the interests of helping drug makers prepare for the new legislative climate, database and software provider Cegedim recently organized a seminar entitled “Is commercial compliance going to be the Achilles heel of the pharmaceutical industry?”. Renowned pharma industry associations directors attended as speakers and delegates coming from the USA, Japan and ten European countries participated.
To receive a copy of the seminar outputs, please send your request to: [email protected]
For more information visit http://www.cegedim-crm.com
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
